Article

Clinically Actionable Pharmacogenomic Variants for Anticancer Therapy in Nigeria: First Comprehensive Variant Profiling in Underrepresented Nigerian Cohorts

2025-11-20

Abstract excerpt

<title>Abstract</title> <p> Background Advances in pharmacogenomic research have ushered in a new era of precision medicine in cancer care. However, evidence on the effects of pharmacogenomic variants on anticancer drug efficacy and safety in the Nigerian population is scarce. As a result, pharmacogenomic testing is not currently included in cancer care in Nigeria. This study aimed to investigate the minor alle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 553e99d8-0f10-51c2-ac04-66edc1c32791
DOI: 10.21203/rs.3.rs-8139291/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinically Actionable Pharmacogenomic Variants for Anticancer Therapy in Nigeria: First Comprehensive Variant Profiling in Underrepresented Nigerian CohortsDOI 10.21203/rs.3.rs-8139291/v1Read

Clinically actionable pharmacogenomic variants for anticancer therapy in Nigeria: first comprehensive variant profiling in underrepresented Nigerian cohorts.Semantic proximity Read

Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population.Semantic proximity Read

Germline oncopharmacogenetics, a promising field in cancer therapy.Semantic proximity Read

Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences.Semantic proximity Read

Cancer Genomics Research in Nigeria: A Scoping Review Protocol v1Semantic proximity Read

Pharmacogenomic analysis and clinical annotation of 635 patients.Semantic proximity Read

Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.Semantic proximity Read

Opportunistic analysis of clinically actionable DPYD gene variants in a germline testing cohort in India.Semantic proximity Read

Pharmacogenetics, Pharmacogenomics, and Individualized MedicineSemantic proximity Read

How to Consider Rare Genetic Variants in Personalized Drug Therapy.Semantic proximity Read

CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERSSemantic proximity Read

Genetic variation in human drug-related genesSemantic proximity Read